Clinical outcome of gemcitabine and carboplatin as second-line chemotherapy for advanced urothelial carcinoma resistant to first-line therapy with methotrexate, vinblastine, doxorubicin, and cisplatin
| Autor: | Junya Furukawa, Ken-ichi Harada, F. Masato, Nobuyuki Hinata, Tomoaki Terakawa |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Oncology
Cisplatin medicine.medical_specialty business.industry Urology lcsh:Diseases of the genitourinary system. Urology lcsh:RC870-923 lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens Second line chemotherapy Methotrexate/Vinblastine lcsh:RC254-282 Gemcitabine Carboplatin chemistry.chemical_compound First line therapy chemistry Internal medicine medicine Doxorubicin business medicine.drug Urothelial carcinoma |
| Zdroj: | European Urology Open Science, Vol 19, Iss, Pp e1584-(2020) |
| ISSN: | 2666-1683 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|